Type 1 Diabetes
<ѻý class="page-description">ѻý>More in Type 1 Diabetes
Data too uncertain to support sotagliflozin in subset with chronic kidney disease, advisors say
Nov 01, 2024
SGLT1/SGLT2 inhibitor has another shot in T1D, but now in more narrow patient population
Oct 30, 2024
But higher severe hypoglycemia risk with efsitora in type 1 diabetes likely precludes its use
Sep 10, 2024
Adolescence is a critical period in T1D, associated with hyperfiltration and high HbA1c levels
Jun 25, 2024
INHALE 3 provides insights into dosing and who might actually do worse than with a pump
Jun 23, 2024